AMREP CORP (AXR) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:AXR • US0321591051

20.86 USD
+0.45 (+2.2%)
Last: Feb 4, 2026, 08:04 PM
Fundamental Rating

7

AXR gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 62 industry peers in the Real Estate Management & Development industry. AXR scores excellent points on both the profitability and health parts. This is a solid base for a good stock. AXR scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make AXR a good candidate for value and quality investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year AXR was profitable.
  • AXR had a positive operating cash flow in the past year.
  • AXR had positive earnings in each of the past 5 years.
  • Each year in the past 5 years AXR had a positive operating cash flow.
AXR Yearly Net Income VS EBIT VS OCF VS FCFAXR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

1.2 Ratios

  • AXR's Return On Assets of 7.49% is amongst the best of the industry. AXR outperforms 96.77% of its industry peers.
  • The Return On Equity of AXR (7.72%) is better than 79.03% of its industry peers.
  • AXR has a better Return On Invested Capital (7.10%) than 88.71% of its industry peers.
  • AXR had an Average Return On Invested Capital over the past 3 years of 7.98%. This is above the industry average of 5.44%.
Industry RankSector Rank
ROA 7.49%
ROE 7.72%
ROIC 7.1%
ROA(3y)11.25%
ROA(5y)11.62%
ROE(3y)11.7%
ROE(5y)12.51%
ROIC(3y)7.98%
ROIC(5y)10.76%
AXR Yearly ROA, ROE, ROICAXR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 22.86%, AXR belongs to the top of the industry, outperforming 93.55% of the companies in the same industry.
  • AXR's Profit Margin has declined in the last couple of years.
  • AXR has a better Operating Margin (24.45%) than 88.71% of its industry peers.
  • AXR's Operating Margin has declined in the last couple of years.
  • AXR has a better Gross Margin (41.05%) than 70.97% of its industry peers.
  • AXR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.45%
PM (TTM) 22.86%
GM 41.05%
OM growth 3Y-12.34%
OM growth 5YN/A
PM growth 3Y-1.77%
PM growth 5YN/A
GM growth 3Y-4.88%
GM growth 5Y19.57%
AXR Yearly Profit, Operating, Gross MarginsAXR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AXR is destroying value.
  • The number of shares outstanding for AXR has been increased compared to 1 year ago.
  • The number of shares outstanding for AXR has been reduced compared to 5 years ago.
  • Compared to 1 year ago, AXR has an improved debt to assets ratio.
AXR Yearly Shares OutstandingAXR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
AXR Yearly Total Debt VS Total AssetsAXR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 18.74 indicates that AXR is not in any danger for bankruptcy at the moment.
  • AXR has a Altman-Z score of 18.74. This is amongst the best in the industry. AXR outperforms 98.39% of its industry peers.
  • AXR has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
  • AXR's Debt to FCF ratio of 0.01 is amongst the best of the industry. AXR outperforms 93.55% of its industry peers.
  • AXR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of AXR (0.00) is better than 88.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 18.74
ROIC/WACC0.8
WACC8.92%
AXR Yearly LT Debt VS Equity VS FCFAXR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 27.73 indicates that AXR has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 27.73, AXR belongs to the best of the industry, outperforming 98.39% of the companies in the same industry.
  • AXR has a Quick Ratio of 10.93. This indicates that AXR is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of AXR (10.93) is better than 96.77% of its industry peers.
Industry RankSector Rank
Current Ratio 27.73
Quick Ratio 10.93
AXR Yearly Current Assets VS Current LiabilitesAXR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The earnings per share for AXR have decreased strongly by -15.00% in the last year.
  • AXR shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.33% yearly.
  • AXR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -27.32%.
  • The Revenue has been growing by 21.46% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-15%
EPS 3Y2.33%
EPS 5YN/A
EPS Q2Q%-70.4%
Revenue 1Y (TTM)-27.32%
Revenue growth 3Y-5.51%
Revenue growth 5Y21.46%
Sales Q2Q%-21.07%

3.2 Future

  • The Earnings Per Share is expected to grow by 2.71% on average over the next years.
  • Based on estimates for the next years, AXR will show a quite strong growth in Revenue. The Revenue will grow by 11.91% on average per year.
EPS Next Y-4.9%
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%
EPS Next 5Y2.71%
Revenue Next Year12.43%
Revenue Next 2Y8.39%
Revenue Next 3Y8.21%
Revenue Next 5Y11.91%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
AXR Yearly Revenue VS EstimatesAXR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M
AXR Yearly EPS VS EstimatesAXR Yearly EPS VS EstimatesYearly EPS VS Estimates 2026 2027 2028 2029 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.64, which indicates a very decent valuation of AXR.
  • 90.32% of the companies in the same industry are more expensive than AXR, based on the Price/Earnings ratio.
  • AXR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.25.
  • With a Price/Forward Earnings ratio of 9.88, the valuation of AXR can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AXR indicates a rather cheap valuation: AXR is cheaper than 95.16% of the companies listed in the same industry.
  • AXR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.50.
Industry RankSector Rank
PE 10.64
Fwd PE 9.88
AXR Price Earnings VS Forward Price EarningsAXR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 100.00% of the companies in the same industry are more expensive than AXR, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of AXR indicates a somewhat cheap valuation: AXR is cheaper than 77.42% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 24.82
EV/EBITDA 5.76
AXR Per share dataAXR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The decent profitability rating of AXR may justify a higher PE ratio.
  • AXR's earnings are expected to decrease with -2.55% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for AXR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AMREP CORP

NYSE:AXR (2/4/2026, 8:04:33 PM)

20.86

+0.45 (+2.2%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)12-12
Earnings (Next)03-05
Inst Owners46.07%
Inst Owner Change-1.72%
Ins Owners45.02%
Ins Owner Change0%
Market Cap110.77M
Revenue(TTM)45.95M
Net Income(TTM)10.50M
Analysts80
Price Target23.46 (12.46%)
Short Float %0.83%
Short Ratio4.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)38.09%
Min EPS beat(2)-50.49%
Max EPS beat(2)126.68%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.16%
Min Revenue beat(2)-37.84%
Max Revenue beat(2)27.52%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-23.33%
PT rev (3m)-23.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)26.67%
EPS NY rev (1m)-0.45%
EPS NY rev (3m)-0.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.28%
Revenue NY rev (1m)-12.55%
Revenue NY rev (3m)-12.55%
Valuation
Industry RankSector Rank
PE 10.64
Fwd PE 9.88
P/S 2.41
P/FCF 24.82
P/OCF 22.13
P/B 0.81
P/tB 0.81
EV/EBITDA 5.76
EPS(TTM)1.96
EY9.4%
EPS(NY)2.11
Fwd EY10.12%
FCF(TTM)0.84
FCFY4.03%
OCF(TTM)0.94
OCFY4.52%
SpS8.65
BVpS25.62
TBVpS25.62
PEG (NY)N/A
PEG (5Y)N/A
Graham Number33.61
Profitability
Industry RankSector Rank
ROA 7.49%
ROE 7.72%
ROCE 8.26%
ROIC 7.1%
ROICexc 10.57%
ROICexgc 10.61%
OM 24.45%
PM (TTM) 22.86%
GM 41.05%
FCFM 9.71%
ROA(3y)11.25%
ROA(5y)11.62%
ROE(3y)11.7%
ROE(5y)12.51%
ROIC(3y)7.98%
ROIC(5y)10.76%
ROICexc(3y)10.52%
ROICexc(5y)13.87%
ROICexgc(3y)10.56%
ROICexgc(5y)13.9%
ROCE(3y)9.27%
ROCE(5y)12.5%
ROICexgc growth 3Y-24.11%
ROICexgc growth 5YN/A
ROICexc growth 3Y-24.15%
ROICexc growth 5YN/A
OM growth 3Y-12.34%
OM growth 5YN/A
PM growth 3Y-1.77%
PM growth 5YN/A
GM growth 3Y-4.88%
GM growth 5Y19.57%
F-Score5
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 223.46%
Cap/Sales 1.18%
Interest Coverage 250
Cash Conversion 43.61%
Profit Quality 42.5%
Current Ratio 27.73
Quick Ratio 10.93
Altman-Z 18.74
F-Score5
WACC8.92%
ROIC/WACC0.8
Cap/Depr(3y)283.02%
Cap/Depr(5y)282.35%
Cap/Sales(3y)0.78%
Cap/Sales(5y)0.91%
Profit Quality(3y)86%
Profit Quality(5y)103.5%
High Growth Momentum
Growth
EPS 1Y (TTM)-15%
EPS 3Y2.33%
EPS 5YN/A
EPS Q2Q%-70.4%
EPS Next Y-4.9%
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%
EPS Next 5Y2.71%
Revenue 1Y (TTM)-27.32%
Revenue growth 3Y-5.51%
Revenue growth 5Y21.46%
Sales Q2Q%-21.07%
Revenue Next Year12.43%
Revenue Next 2Y8.39%
Revenue Next 3Y8.21%
Revenue Next 5Y11.91%
EBIT growth 1Y-11.28%
EBIT growth 3Y-17.16%
EBIT growth 5YN/A
EBIT Next Year19.88%
EBIT Next 3Y1.05%
EBIT Next 5Y6.19%
FCF growth 1Y-50.66%
FCF growth 3Y-12.03%
FCF growth 5Y66.27%
OCF growth 1Y-45.53%
OCF growth 3Y-12.86%
OCF growth 5Y67.79%

AMREP CORP / AXR FAQ

What is the fundamental rating for AXR stock?

ChartMill assigns a fundamental rating of 7 / 10 to AXR.


What is the valuation status of AMREP CORP (AXR) stock?

ChartMill assigns a valuation rating of 7 / 10 to AMREP CORP (AXR). This can be considered as Undervalued.


How profitable is AMREP CORP (AXR) stock?

AMREP CORP (AXR) has a profitability rating of 7 / 10.


How financially healthy is AMREP CORP?

The financial health rating of AMREP CORP (AXR) is 9 / 10.